These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21716952)

  • 41. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
    Zhu Z; Hong Y; Wang Y; He G; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
    Schilling V; Bujia J; Negri B; Kastenbauer E
    Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
    Ergün S; Zheng X; Carlsöö B
    Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis.
    Schilling V; Lang S; Rasp G; Mack B; Nerlich A
    Acta Otolaryngol; 1996 Sep; 116(5):741-6. PubMed ID: 8908253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Residual Disease Following Transcanal Totally Endoscopic vs Postauricular Surgery Among Children With Middle Ear and Attic Cholesteatoma.
    Dixon PR; James AL
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):408-413. PubMed ID: 32134439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of transforming growth factor-alpha (TGF-alpha) in cholesteatoma.
    Shiwa M; Kojima H; Moriyama H
    J Laryngol Otol; 1998 Aug; 112(8):750-4. PubMed ID: 9850316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunohistochemical detection of c-myc proto-oncogene products in middle ear cholesteatoma].
    Holly A; Sittinger M; Bujía J
    Laryngorhinootologie; 1995 Jun; 74(6):348-51. PubMed ID: 7662077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.
    Xie S; Pan Z; Yin T; Ren J; Liu W
    Acta Otolaryngol; 2020 May; 140(5):351-355. PubMed ID: 32108533
    [No Abstract]   [Full Text] [Related]  

  • 51. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical investigations on external auditory canal cholesteatomas.
    Adamczyk M; Sudhoff H; Jahnke K
    Otol Neurotol; 2003 Sep; 24(5):705-8. PubMed ID: 14501442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
    Liu D; Ma X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunomorphological evaluation of cholesteatoma].
    Kuczkowski J; Bakowska A; Mikaszewski B
    Otolaryngol Pol; 2004; 58(2):289-95. PubMed ID: 15307474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A study on the state of cell proliferation and apoptosis in human middle ear cholesteatoma].
    Yu Q; Jin K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):450-1. PubMed ID: 12541689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical study on proliferative activity of experimental cholesteatoma.
    Park K; Park HJ; Chun YM
    Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):101-5. PubMed ID: 11374247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].
    Olszewska E; Chodynicki S; Chyczewski L
    Otolaryngol Pol; 2003; 57(1):85-9. PubMed ID: 12741150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.